Compare TCGL & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCGL | MBOT |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.6M | 126.3M |
| IPO Year | 2025 | N/A |
| Metric | TCGL | MBOT |
|---|---|---|
| Price | $5.62 | $2.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 662.9K | ★ 2.7M |
| Earning Date | 12-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,274,647.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,107.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.80 | N/A |
| 52 Week Low | $3.95 | $0.93 |
| 52 Week High | $5.91 | $4.67 |
| Indicator | TCGL | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 50.02 |
| Support Level | N/A | $1.70 |
| Resistance Level | N/A | $2.55 |
| Average True Range (ATR) | 0.00 | 0.15 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 0.00 | 60.00 |
TechCreate Group Ltd is a technology consultancy and advanced software solution provider offering a comprehensive range of payment, cybersecurity, and digital services and solutions. It serves large institutions, financial institutions and telecommunication companies, by providing them with payment, cybersecurity, and digital solutions such as, the development of RTE, RTP, API management and other services, such as cybersecurity defense, IT infrastructure, and cloud services. Its core business areas comprise: (1) the provision of professional services, (2) the sale of software licenses and maintenance licenses, and (3) the sale of hardware solutions.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.